4//SEC Filing
Bopitiya Ranmali 4
Accession 0001562180-24-004663
CIK 0001568651other
Filed
Jun 3, 8:00 PM ET
Accepted
Jun 4, 6:05 PM ET
Size
23.0 KB
Accession
0001562180-24-004663
Insider Transaction Report
Form 4
Bopitiya Ranmali
EVP & Chief Legal Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-06-01−16,447→ 180,922 total→ Class A Common Stock (16,447 underlying) - Exercise/Conversion
Class A Common Stock
2024-06-01+16,447→ 150,136 total - Exercise/Conversion
Class A Common Stock
2024-06-01+20,425→ 133,689 total - Sale
Class A Common Stock
2024-06-04$19.09/sh−447$8,533→ 137,388 total - Exercise/Conversion
Restricted Stock Units
2024-06-01−4,867→ 53,537 total→ Class A Common Stock (4,687 underlying) - Exercise/Conversion
Class A Common Stock
2024-06-01+4,867→ 155,003 total - Exercise/Conversion
Restricted Stock Units
2024-06-01−20,425→ 142,974 total→ Class A Common Stock (20,425 underlying) - Sale
Class A Common Stock
2024-06-03$19.46/sh−17,168$334,089→ 137,835 total
Footnotes (7)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
- [F2]The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.82, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.01 to $19.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- [F5]The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2022.
- [F6]The restricted stock units vest over a four-year period in 16 equal quarterly installments beginning on June 1, 2023.
- [F7]The restricted stock units vest over a three-year period in 12 equal quarterly installments beginning on June 1, 2024.
Issuer
Oscar Health, Inc.
CIK 0001568651
Entity typeother
Related Parties
1- filerCIK 0001908069
Filing Metadata
- Form type
- 4
- Filed
- Jun 3, 8:00 PM ET
- Accepted
- Jun 4, 6:05 PM ET
- Size
- 23.0 KB